Skip to content Skip to footer
Close

Clinicals

Recap with ID-Cap®: Monitoring HIV Medication Adherence in University of Colorado’s QUANTI-TAF Study

In collaboration with the University of Colorado, etectRx has made significant strides in advancing medication adherence monitoring through the QUANTI-TAF study (NCT04065347). Recently published in Clinical Infectious Diseases1 and the British Journal of Clinical Pharmacology2, the QUANTI-TAF study focused on antiretroviral therapy (ART) adherence among persons with HIV (PWH) receiving daily oral tenofovir alafenamide/emtricitabine (TAF/FTC)-based ART for at least

Read More »
March 3, 2025

ALOHA! Adherence: ID-Cap™ Clinical Trial Research Presented at the 2024 Hawaii International Conference on System Sciences (HICSS)

The ID-Cap™ System embarks on a promising journey in 2024, receiving continued praise from clinical trials. Researchers from Brigham and Women’s Hospital and Ohio State University welcomed the new year in sunny Honolulu to present valuable clinical trial data at the Hawaii International Conference on System Sciences (HICSS) 2024. The momentum of medication adherence carried

Read More »
January 24, 2024

ID Cap™ System Evolution: Introducing the Wrist-Worn Reader

The development of a Wrist-Worn Reader is the latest advancement to the ID-Cap™ System, offering a promising solution to address the complex issue of medication non-adherence. Medication nonadherence is a widespread problem, resulting in significant healthcare costs and challenges for individuals managing chronic conditions.  In particular, adherence is crucial in the context of HIV prevention, where

Read More »
November 6, 2023

Global Growth: University of Cape Town Announces ID-Cap™ System Acceptability Study

University of Cape Town announces ID-Cap™ System acceptability study in South Africa. Mass General Brigham in collaboration with University of Cape Town is conducting a new research study to assess the feasibility and acceptability of a digital pill system for monitoring medication adherence in individuals with HIV-TB co-infection in South Africa. Adherence to medication regimens

Read More »
October 23, 2023

ID-Cap™ System Powers Historic HIV Digital Pill Study

etectRx announces record-breaking use of the ID-Cap™ System, utilized in University of Colorado’s HIV treatment study. The Quantification of Tenofovir Alafenamide Adherence and Exposure in Adults living with HIV (QUANTI-TAF) study evaluated drug concentrations in dried blood spots (DBS), in tandem with medication adherence measured by the ID-Cap™ System. The ID-Cap™ System’s remote patient monitoring

Read More »
October 9, 2023

Preliminary Analysis of Real-Time Therapy-Based Interventions with ID-Cap™ System Demonstrates Effectiveness of Maintaining Adherence for High-Risk Populations

NCT03512418- An ongoing study designed to evaluate PrEP adherence data using cognitive behavioral therapy based interventions delivered through the ID-Cap™ System in MSM (men who have sex with men) participants with substance abuse who receive oral PrEP (HIV pre-exposure prophylaxis). Early trial results from 10 pilot study subsample participants demonstrate the effectiveness of intervention messages following

Read More »
August 28, 2023

High Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic

COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from etectRx resumed in July of 2020. etectRx sought to understand if patients were engaged with our digital pill system when used to track and report their medication-taking in a clinical

Read More »
March 24, 2023

Remote Therapy Monitoring Billing Guide

In 2022 the Centers for Medicare and Medicaid Services (CMS) expanded its digital health coverage and began reimbursing providers for remote therapy monitoring (RTM). RTM differs from existing Remote Patient Monitoring (RPM) in that it monitors therapeutic data, such as medication adherence. RPM measures physiologic data, such as blood pressure and heart rate. Unlike the

Read More »
March 24, 2023

Leading Digital Pill Solution Surpasses 10,000 Ingestions

etectRx™, Inc. (etectRx™), the standard in FDA-cleared digital medication adherence, today announced that its digital pill, the ID-Cap System has surpassed 10,000 ingestions, a significant milestone for the company with a reputation for demonstrating strong results and providing data to accurately track patients’ adherence to their oral medications. Continue Reading

Read More »
March 24, 2023